These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
720 related articles for article (PubMed ID: 28697808)
1. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China. Che Y; Bo D; Lin X; Chen T; He T; Lin Y BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China. Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021 [TBL] [Abstract][Full Text] [Related]
9. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582 [TBL] [Abstract][Full Text] [Related]
10. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China. Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878 [TBL] [Abstract][Full Text] [Related]
11. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143 [TBL] [Abstract][Full Text] [Related]
12. Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China. Li D; Hu Y; Werngren J; Mansjö M; Zheng X; Drobniewski F; Hoffner S; Xu B Antimicrob Agents Chemother; 2016 Sep; 60(9):5159-66. PubMed ID: 27297481 [TBL] [Abstract][Full Text] [Related]
13. [Prevalence and transmission of pyrazinamide-resistant Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376 [No Abstract] [Full Text] [Related]
14. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects. Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296 [TBL] [Abstract][Full Text] [Related]
15. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations. Gu Y; Yu X; Jiang G; Wang X; Ma Y; Li Y; Huang H Diagn Microbiol Infect Dis; 2016 Mar; 84(3):207-11. PubMed ID: 26775806 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China. Xu P; Wu J; Yang C; Luo T; Shen X; Zhang Y; Nsofor CA; Zhu G; Gicquel B; Gao Q Tuberculosis (Edinb); 2016 May; 98():56-61. PubMed ID: 27156619 [TBL] [Abstract][Full Text] [Related]
17. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm. Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253 [TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar. Ei PW; Mon AS; Htwe MM; Win SM; Aye KT; San LL; Zaw NN; Nyunt WW; Myint Z; Lee JS; Aung WW Tuberculosis (Edinb); 2020 Dec; 125():102013. PubMed ID: 33142220 [TBL] [Abstract][Full Text] [Related]
19. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001 [TBL] [Abstract][Full Text] [Related]
20. Characterization of pyrazinamide resistance in consecutive multidrug-resistant Mansjo M; Werngren J; Hoffner S Int J Mycobacteriol; 2017; 6(2):156-161. PubMed ID: 28559517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]